跳至主要内容
临床试验/NL-OMON56723
NL-OMON56723尚未招募不适用

CYtosorb modulation of surgiCal infLammatiON during LVAD insErtion (CYCLONE-LVAD) - CYCLONE-LVAD

Imperial College London0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adult patients (>=18 years), but <=70 years;
  • Scheduled for elective CF-LVAD implantation with the use of cardiopulmonary
  • Written informed consent for participation.

排除标准

  • Poor spoken and/or written language comprehension
  • Declined or missing informed consent
  • LVAD implant planned without use of CPB
  • Total Artificial Heart implantation
  • Planned CPB temperature*<*32 °C
  • AIDS with a CD4 count of*<*200/µL
  • Severe thrombocytopenia (PLT <50000/microliter)
  • Application of contrast medium on the day of surgery
  • Immunosuppressive therapy or long-term therapy with corticosteroids
  • Contraindication to anticoagulation with heparin
  • - Patients receiving anticonvulsive therapy, including carbamazepine,
  • lamotrigine, oxcarbazepine, phenytoin, quetiapine and valproat
  • Participation in another clinical intervention trial

研究者

相似试验